Navigation Links
Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours
Date:3/12/2009

CALGARY, March 12 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) announced today that it has started patient enrolment in a Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC) with K-RAS or EGFR-activated tumours. The Principal Investigator is Dr. Miguel Villalona-Calero, Professor, Division of Hematology/Oncology and Department of Internal Medicine and Pharmacology at The Ohio State University Comprehensive Cancer Center.

"We are quite excited about this trial, since there are no known therapies that to date have effectively targeted K-RAS in cancer patients," said Dr. Villalona-Calero. "If this therapy works, this could substantially impact the outlook for our patients."

This trial (REO 016) is a single arm, single-stage, open-label, Phase 2 study of REOLYSIN(R) given intravenously with paclitaxel and carboplatin every 3 weeks. Patients will receive four to six cycles of paclitaxel and carboplatin in conjunction with REOLYSIN(R), at which time REOLYSIN(R) may be continued as a monotherapy. It is anticipated that up to 36 patients will be treated in this trial.

Eligible patients include those with metastatic or recurrent NSCLC with K-RAS or EGFR-activated tumours, who have not received chemotherapy treatment for their metastatic or recurrent disease. Patients must have demonstrated mutations in K-RAS or EGFR, or EGFR gene amplification in their tumours (metastatic or primary) in order to qualify for the trial.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cancer Therapy & Research Center at The University of Texas Health Science Center and Oncolytics Biotech(R) Inc. Announce Multi-Trial Clinical Research Collaboration
2. Oncolytics Biotech Inc. Announces Start of Patient Enrolment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients with Metastatic Colorectal Cancer
3. InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study
4. Avineuro Pharmaceuticals, Inc. Announces Beginning of Phase I Clinical Studies of AVN-211, Potent Small Molecule for Treatment of Schizophrenia.
5. Cardiums InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
6. Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
7. NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection
8. AndroScience Corporation Announces Phase 2a Study Results on ASC-J9(TM) for the Treatment of Acne
9. AMA Foundation Announces Seed Grant Research Recipients
10. Galderma Announces Interim Data Relating to Sequential Treatment Regimen of Clobex(R) Spray Followed by Vectical(TM) Ointment in Managing Plaque Psoriasis
11. Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014 China Biologic Products, ... leading fully integrated plasma-based biopharmaceutical company in ... to release second quarter 2014 financial results on Tuesday, ... The Company,s management will hold a conference call ... which is 8:00 p.m., Beijing Time on August 6, ...
(Date:7/29/2014)... --  Health 2.0 announces Bernard Tyson , CEO ... Eric Topol , Patrick Soon-Shiong , and Samsung,s President ... Annual Fall Conference this coming Sept. 21-24 in ... is set to host the very first Wearable Tech Fashion ... Consumer Tech & Wearables: Powering Healthy Lifestyles. The panel ...
(Date:7/28/2014)... July 28, 2014  Dignity Health St. Mary,s ... the Get With The Guidelines®-Stroke Silver-Plus Quality Achievement ... by the American Heart Association/American Stroke Association for ... number four cause of death and a leading ... United States , according to the American ...
Breaking Medicine Technology:China Biologic to Report Second Quarter 2014 Financial Results 2China Biologic to Report Second Quarter 2014 Financial Results 3Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 2Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 3Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3
... 2011 Advanced Life Sciences Holdings, ... cancelled its Annual Meeting of Shareholders, which was previously ...   (Logo:   http://photos.prnewswire.com/prnh/20080218/ALSLOGO ) ... Life Sciences is a biopharmaceutical company engaged in the ...
... Amgen (NASDAQ: AMGN ), today announced results of ... The Fairmont Olympic Hotel in Seattle, Wash. Approximately 86.32 percent ... The director nominees David Baltimore, Frank J. Biondi, Jr., ... C. Herringer, Gilbert S. Omenn, Judith C. Pelham, J. Paul ...
Cached Medicine Technology:Amgen Announces Voting Results Of Annual Meeting of Stockholders 2Amgen Announces Voting Results Of Annual Meeting of Stockholders 3Amgen Announces Voting Results Of Annual Meeting of Stockholders 4
(Date:7/29/2014)... Cold Spring Harbor, NY -- Researchers at Cold Spring Harbor ... most important tumor-suppressing protein. Called p53, this protein has been ... the fore when healthy cells sense damage to their DNA ... intense exposure to the sun,s UV rays. If the ... preprogrammed cell-death, or apoptosis. Mutant versions of p53 that ...
(Date:7/29/2014)... Transformer Oil Market in Europe report defines and segments the ... revenue. The Transformer Oil market in Europe is estimated to ... by 2018, at a CAGR of 7.8% from 2013 to ... Market in Europe report, to get an idea of the ... segmentation in the Transformer Oil market in Europe, and is ...
(Date:7/29/2014)... Doug and Sandra Williams have been growing ... their grow-your-own log kits for almost that long. Naturally, these ... a treat for their guests. A new video ... Lost Creek Mushroom Farm online coverage. , They started growing ... turned to selling the logs instead of the mushrooms, as ...
(Date:7/29/2014)... 29, 2014 Representatives with BNatrl announced ... called BNatrl Silver Solution 12ppm . , “It’s ... spokesperson for BNatrl LLC. “It helps boost your immune ... harmful pathogens and microbes.” , BNatrl develops and manufactures ... products, with 10 percent of profits being used to ...
(Date:7/29/2014)... According to the new market research report, ... Material (Optical Prism, Pizeoelectric, Capacitive, and Adhesives), Application ... Banking & Finance), and Geography - Global Trends ... MarketsandMarkets, the global Fingerprint Sensors Market is projected ... a high CAGR of 16.8% from 2014 to ...
Breaking Medicine News(10 mins):Health News:Research may explain how foremost anticancer 'guardian' protein learned to switch sides 2Health News:Europe Transformer Oil Market is Expected to Reach $0.5 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Transformer Oil Market is Expected to Reach $0.5 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Transformer Oil Market is Expected to Reach $0.5 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Lost Creek Mushroom Farm Cooks Up a Company Dish from Shiitake Mushrooms Grown on Logs With Grow-Your-Own Log Kits 2Health News:Lost Creek Mushroom Farm Cooks Up a Company Dish from Shiitake Mushrooms Grown on Logs With Grow-Your-Own Log Kits 3Health News:Lost Creek Mushroom Farm Cooks Up a Company Dish from Shiitake Mushrooms Grown on Logs With Grow-Your-Own Log Kits 4Health News:BNatrl Launches New Silver Solution Product 2Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 4
... between seeing letter and the sound it represents, study ... brain scans reveal more about how the minds of ... to be a mismatch between seeing the letter and ... said researchers from the University of Maastricht in the ...
... to heart attacks than their predecessors, researchers say , , THURSDAY, ... good shape, even when compared with their counterparts 10 or ... study, more aging boomers are being hospitalized for heart attacks ... the increase in cases could place a big burden on ...
... KIBBUTZ SHAMIR, Israel, March 12 Shamir Optical Industry Ltd. ... fourth quarter and year end 2008 earnings results on Wednesday, ... discuss the results at 10:00 A.M. EDT that morning. The ... To listen live, please go to www.kcsa.com approximately ...
... EAST LANSING, Mich., March 12 ... has been recognized for the third consecutive year for ... to MESSA members.MESSA was honored for providing efficient and ... by The Center for Customer-Driven Quality(TM) at Purdue ...
... Include Care Management Software Applications As Part of ... TCS Healthcare Technologies (TCS), an ... software applications, supports the health information technology (IT) ... to as the American Recovery and Reinvestment Act ...
... , , THURSDAY, March 12 (HealthDay News) -- More than ... the sky over land has been should reveal how ... to a University of Maryland-led team of researchers. , ... sky visibility over land has decreased worldwide since the ...
Cached Medicine News:Health News:Brain Scans Shed Light on Dyslexia 2Health News:Brain Scans Shed Light on Dyslexia 3Health News:Aging Baby Boomers May Swamp Cardiac Care 2Health News:Aging Baby Boomers May Swamp Cardiac Care 3Health News:Shamir Optical Industry Ltd. to Host Conference Call Announcing Fourth Quarter and Year End 2008 Earnings Results 2Health News:MESSA Receives National Recognition for Best Practices in Providing Efficient, Cost-Effective Customer Service 2Health News:MESSA Receives National Recognition for Best Practices in Providing Efficient, Cost-Effective Customer Service 3Health News:TCS Healthcare Technologies Offers Health IT Solutions That Support Health Care Reform 2Health News:TCS Healthcare Technologies Offers Health IT Solutions That Support Health Care Reform 3Health News:Clear Skies Have Become Less So Over Time, Data Show 2
Instrument necessary for insertion of Ritleng Bicanaliculus systems and of Self-Threading Monoka systems....
... This unique system uses prolene as thread-guide ... intubation. The hollow Ritleng Probe is inserted ... prolene thread-guide is fed through it. The ... thread to pull the silicone tubing in ...
... system uses prolene as thread-guide reducing time ... hollow Ritleng Probe is inserted into the ... is fed through it. The probe is ... pull the silicone tubing in place. Newly ...
For Canalicular Stenosis in Infants. Medical grade silicone. Note: Can also be used in DCR because of its high flexibility. Probe entirely embedded in silicone tubing (non-traumatic). Box of 3, steri...
Medicine Products: